- Home
- DTF vs EDAP Comparison
DTF vs EDAP Comparison
Compare DTF & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTF
- EDAP
- Stock Information
- Founded
- DTF 1991
- EDAP 1979
- Country
- DTF United States
- EDAP France
- Employees
- DTF N/A
- EDAP N/A
- Industry
- DTF Investment Managers
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DTF Finance
- EDAP Health Care
- Exchange
- DTF Nasdaq
- EDAP Nasdaq
- Market Cap
- DTF 79.5M
- EDAP 81.6M
- IPO Year
- DTF N/A
- EDAP 1997
- Fundamental
- Price
- DTF $11.01
- EDAP $2.19
- Analyst Decision
- DTF
- EDAP Strong Buy
- Analyst Count
- DTF 0
- EDAP 1
- Target Price
- DTF N/A
- EDAP $19.00
- AVG Volume (30 Days)
- DTF 21.1K
- EDAP 227.8K
- Earning Date
- DTF 01-01-0001
- EDAP 11-07-2024
- Dividend Yield
- DTF 3.64%
- EDAP N/A
- EPS Growth
- DTF N/A
- EDAP N/A
- EPS
- DTF 0.44
- EDAP N/A
- Revenue
- DTF N/A
- EDAP $70,722,730.00
- Revenue This Year
- DTF N/A
- EDAP $6.96
- Revenue Next Year
- DTF N/A
- EDAP $15.53
- P/E Ratio
- DTF $24.34
- EDAP N/A
- Revenue Growth
- DTF N/A
- EDAP 12.17
- 52 Week Low
- DTF $10.29
- EDAP $2.14
- 52 Week High
- DTF $11.19
- EDAP $8.50
- Technical
- Relative Strength Index (RSI)
- DTF 25.84
- EDAP 41.04
- Support Level
- DTF $11.27
- EDAP $2.16
- Resistance Level
- DTF $11.34
- EDAP $2.43
- Average True Range (ATR)
- DTF 0.07
- EDAP 0.16
- MACD
- DTF -0.03
- EDAP 0.00
- Stochastic Oscillator
- DTF 0.00
- EDAP 9.43
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTFTax-Free Income Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax consistent with preservation of capital. The fund seeks to achieve its investment objective by investing in a diversified portfolio of investment-grade tax-exempt obligations.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.